Tyra Biosciences, Inc. (TYRA) stock
TYRANasdaqPharmaceutical PreparationsFiscal year ends December 31
$20.02+0.26 (+1.32%)
Close on Nov 13, 2026Market cap $1.20BP/E –Yield –
Tyra Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Tyra Biosciences's enterprise value was $1.18B on Nov 11, 2026, against $1.14B a year earlier. Over the last 5 years it ranged from -$7.71M to $1.98B, with a median of $482.68M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.18B | -12.1% |
| 2025 | Dec 31, 2025 | $1.34B | +112.3% |
| 2024 | Dec 31, 2024 | $631.03M | +66.5% |
| 2023 | Dec 29, 2023 | $378.91M | +564.4% |
| 2022 | Dec 30, 2022 | $57.03M | -78.6% |
| 2021 | Dec 31, 2021 | $266.97M | – |
See a number that looks wrong?